Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
1993-2-24
|
pubmed:abstractText |
Recent research was shown that oxygen-derived free radicals are involved in the pathogenesis of various diseases, including ischemia-reperfusion injury. We have also reported that oxygen-derived free radicals and lipid peroxidation may play an important role in gastric mucosal injury induced by ischemia-reperfusion. The hypoxanthine-xanthine oxidase system and neutrophils are considered important sources of oxygen-derived free radicals in this process. In recent years, it also has been shown that serum platelet-activating factor (PAF) levels increased during ischemia-reperfusion, and that induction of superoxide generation by neutrophils is one of the important biological effects of PAF. In the present study, we examined the effect of CV-6209, a specific PAF receptor antagonist, on gastric mucosal injury induced by ischemia-reperfusion, to shed some light on the possible involvement of PAF in such lesions. CV-6209 significantly attenuated the gastric mucosal injury induced by ischemia-reperfusion, and inhibited both an increase of thiobarbituric acid reactive substances and a decrease of alpha-tocopherol in gastric mucosa after ischemia-reperfusion. However, CV-6209 had no effect on gastric mucosal blood flow during ischemia-reperfusion. These results suggest that endogenous PAF may play an important role in gastric mucosal injury induced by ischemia-reperfusion, and that CV-6209 exerts its beneficial effect mainly by inhibiting neutrophil superoxide production induced by PAF.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/CV 6209,
http://linkedlifedata.com/resource/pubmed/chemical/Platelet Activating Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Pyridinium Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Thiobarbituric Acid Reactive...,
http://linkedlifedata.com/resource/pubmed/chemical/Vitamin E
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0024-4201
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1058-60
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:1487954-Animals,
pubmed-meshheading:1487954-Gastric Mucosa,
pubmed-meshheading:1487954-Male,
pubmed-meshheading:1487954-Platelet Activating Factor,
pubmed-meshheading:1487954-Pyridinium Compounds,
pubmed-meshheading:1487954-Rats,
pubmed-meshheading:1487954-Rats, Inbred Strains,
pubmed-meshheading:1487954-Rats, Sprague-Dawley,
pubmed-meshheading:1487954-Regional Blood Flow,
pubmed-meshheading:1487954-Reperfusion Injury,
pubmed-meshheading:1487954-Thiobarbituric Acid Reactive Substances,
pubmed-meshheading:1487954-Vitamin E
|
pubmed:year |
1992
|
pubmed:articleTitle |
Effects of a platelet-activating factor antagonist, CV-6209, on gastric mucosal lesions induced by ischemia-reperfusion.
|
pubmed:affiliation |
First Department of Medicine, Kyoto Prefectural University of Medicine, Japan.
|
pubmed:publicationType |
Journal Article
|